UPDATE 1-Nestle boosts skincare business with $1.4 bln Valeant deal

ZURICH, May 28 (Reuters) - Nestle SA said on Wednesday it was boosting its emerging skincare business by buying the rights to several dermatology products from Canada's Valeant Pharmaceuticals International Inc for $1.4 billion in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.